Biochemical researches indicate lots of MAPKs can be activated by MAP3K3, such as ERK1/2, c-Jun N-terminal kinases (JNKs) as well as p38 [21], suggesting the importance of MAP3K3 in cancers. Here, MAP3K3 is linked to cancer.